Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07HYR
|
||||
Former ID |
DIB015139
|
||||
Drug Name |
GCC-1290K
|
||||
Synonyms |
GC-1290K; GC-2101; GCC-1290A; GCC-1290K (salt formulation, oral), Green Cross; Dopamine modulators (Parkinson's disease, oral), Kangwon University/Green Cross; (+)-3-hydroxymorphinan; 3-HM; 3-HM prodrugs (Parkinson's disease), Green Cross; 3-hydroxymorphinan prodrugs (Parkinson's disease), Green Cross
|
||||
Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Phase 1 | [530122] | ||
Company |
Kangwon University Pharmaceutical College
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
[C@]123c4cc(ccc4C[C@@H]([C@H]1CCCC2)NCC3)OCOC(=O)OC(C)C<br />.OC(=O)[C@@H]([C@H](C(=O)O)O)O.O
|
||||
Target and Pathway | |||||
Target(s) | Voltage-dependent calcium channel | Target Info | Modulator | [530122] | |
Protein kinase C | Target Info | Modulator | [530122] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.